CJC-1295 No DAC + Ipamorelin 20 mg

Description

CJC-1295 No DAC + Ipamorelin 20 mg – Synergistic Growth Hormone Peptide Blend

CJC-1295 No DAC + Ipamorelin 20 mg is a high-purity research peptide blend combining two powerful growth-hormone-stimulating peptides: CJC-1295 (without DAC) and Ipamorelin. This formulation is designed for laboratory and pre-clinical research into endogenous growth hormone regulation, metabolism, body composition, recovery, and cellular repair mechanisms.

For research use only — not approved for human or veterinary therapeutic use.

What Is It?

CJC-1295 (No DAC) is a modified Growth Hormone Releasing Hormone (GHRH) analog that stimulates the pituitary gland to increase growth hormone (GH) release in controlled experimental systems. Unlike the DAC-bound version, the no-DAC form has a shorter half-life and produces pulsatile GH release suitable for detailed mechanistic studies.

Ipamorelin is a selective growth hormone secretagogue (GHS) that stimulates the ghrelin receptor (GHS-R1a), triggering bursts of GH secretion with minimal effect on other hormonal pathways such as cortisol or prolactin.

Combined, these peptides provide a dual-mechanism approach to growth hormone axis activation in research models.

Key Research Applications

• This peptide blend is widely used in pre-clinical and laboratory studies to explore:
• Endocrine signaling and GH/IGF-1 axis modulation
• Growth hormone pulsatility and receptor cross-talk mechanisms
• Metabolic regulation and body-composition pathways
• Cellular recovery, repair, and regeneration signaling
• Comparative peptide biology and endocrine physiology

Product Features

• Total peptide content: 20 mg blend of CJC-1295 (No DAC) and Ipamorelin
• Lyophilized powder for stability and long shelf life
• Optimized for reproducibility in in-vitro and pre-clinical research
• Research use only